Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
-3.42%
↓ 28% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthRecovering
Average
-2.68%
Historical baseline
PeriodValue
2025-3.42%
2024-14.61%
2023-8.07%
2022-11.24%
2021-20.74%
2020-40.31%
2019-0.69%
2018100.97%
201716.48%
2016-45.13%